Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > The effects of Trikafta/Kaftrio on people with CF who have mutations other than the most common CF mutation (F508del)

The effects of Trikafta/Kaftrio on people with CF who have mutations other than the most common CF mutation (F508del)

Resource Type

CF Research News

Authors

Galit Livnat, Adi Dagan, Moshe Heching, Einat Shmueli, Dario Prais, Karin Yaacoby-Bianu, Nili Stein, Meir Mei-Zahav, Michal Gur, Malena Cohen-Cymberknoh, Michal Shteinberg

References

J Cyst Fibros. 2022 Nov 10;S1569-1993(22)01393-5. doi: 10.1016/j.jcf.2022.10.011.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Care of patients with CF [3]
Lung Disease and Infection [4]
Pulmonology [5]

Keywords

Elexacaftor/tezacaftor/ivacaftor [6]
Non-F508del mutations [7]
treatment [8]

Date

Thursday, November 10, 2022

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [9]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/effects-trikaftakaftrio-people-cf-who-have-mutations-other-most

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-22-00175R2_FINAL_Shteinberg_111222.pdf [2] https://pubmed.ncbi.nlm.nih.gov/36372699/ [3] https://www.ecfs.eu/research-article-themes/care-patients-cf [4] https://www.ecfs.eu/research-article-themes/lung-disease-and-infection [5] https://www.ecfs.eu/research-article-themes/pulmonology [6] https://www.ecfs.eu/research-article-keywords/elexacaftortezacaftorivacaftor [7] https://www.ecfs.eu/research-article-keywords/non-f508del-mutations [8] https://www.ecfs.eu/research-article-keywords/treatment [9] https://www.ecfs.eu/resource-guideline-type/other-guidelines